Sort by
Refine Your Search
-
Category
-
Country
-
Employer
- Harvard University
- Nanyang Technological University
- Zintellect
- City of Hope
- National University of Singapore
- University of Maryland, Baltimore
- Indiana University
- Northeastern University
- University of Birmingham
- University of Michigan
- University of Oslo
- Dana-Farber Cancer Institute (DFCI)
- University of Colorado
- Florida International University
- King's College London
- SciLifeLab
- UNIVERSITY OF MELBOURNE
- University of British Columbia
- Università degli Studi di Padova
- ADELAIDE UNIVERSITY
- Aarhus University
- Center for Biologics Evaluation and Research (CBER)
- Cold Spring Harbor Laboratory
- Delaware State University
- Margaret M Redfield
- Marquette University
- NTNU - Norwegian University of Science and Technology
- National Center for Toxicological Research (NCTR)
- Queen's University Belfast;
- Stazione Zoologica Anton Dohrn
- The University of Queensland
- UNIVERSITY OF HELSINKI
- University of Bergen
- University of California
- University of California, Los Angeles
- University of Cincinnati
- University of Leeds
- University of London
- University of Michigan (U-M)
- University of Michigan - Ann Arbor
- University of North Carolina at Charlotte
- University of Oxford
- University of Texas at Austin
- Université de Strasbourg
- Weill Cornell Medicine - Chandwani Laboratory
- eQuest
- 36 more »
- « less
-
Field
-
USDA-ARS Molecular Biology Postdoctoral Fellowship in the Natural Products Utilization Research Unit
involving physiological, biochemical, and molecular experiments and the use of numerous techniques such as RNA-seq, data mining of DNA and protein sequence databases, analysis of gene function via CRISPR/Cas
-
openness to new perspectives Desired qualifications Experience with ChIP-seq, ATAC-seq/scATAC-seq, RNA-seq/scRNA-seq, WGS, WGBS, or Hi-C data analysis Experience in computational genome studies (e.g., TF-DNA
-
Pharmaceuticals (Nasdaq: ALNY) has led the translation of RNA interference (RNAi) into a whole new class of innovative medicines with the potential to transform the lives of people afflicted with rare and more
-
Pharmaceuticals (Nasdaq: ALNY) has led the translation of RNA interference (RNAi) into a whole new class of innovative medicines with the potential to transform the lives of people afflicted with rare and more
-
, including models customized for fungal genomes. Training will include crop and fungal RNA-seq analysis; integration of multi-omic and phenotypic data; protein-interaction and structure-based analyses; and
-
in-house high-throughput and Big Data facilities for RNA-seq, scRNA-seq, microarray analysis, and bioinformatics including high-performance computation. You will participate in the research project
-
of diverse PRRSV strains causing extreme pathogenesis and disease. Transcriptomics datasets have been generated via bulk and single-cell RNA sequencing from blood and disease-affected tissues and will be
-
openness to new perspectives Desired qualifications Experience with ChIP-seq, ATAC-seq/scATAC-seq, RNA-seq/scRNA-seq, WGS, WGBS, or Hi-C data analysis. Experience in computational genome studies (e.g., TF
-
: Conducting the research to address the molecular mechanisms at the atomic level that underlies the adverse effects of the environmentally-induced RNA modifications including RNA damage and m6A on DNA damage
-
morphology. Design, coordinate and interpret bulk RNA-sequencing experiments with the project bioinformatician. 'Analyse, interpret and integrate experimental data from cellular, imaging and transcriptomic